References
- Lumigan [package insert]Irvine, CAAllergan, Inc2006
- CracknellKPGriersonIProstaglandin analogues in the anterior eye: Their pressure lowering action and side effectsExp Eye Res200988478679118930047
- Arranz-MarquezETeusMAProstanoids for the management of glaucomaExpert Opin Drug Saf20087680180818983226
- AlexanderCLMillerSJAbelSRProstaglandin analog treatment of glaucoma and ocular hypertensionAnn Pharmacother200236350451111895065
- BrubakerRFMechanism of action of bimatoprost (Lumigan)Surv Ophthalmol200145Suppl 4S347S35111434937
- CohenJSGrossRLCheethamJKVanDenburghAMBernsteinPWhitcupSMTwo-year double-masked comparison of bimatoprost with timolol in patients with glaucoma or ocular hypertensionSurv Ophthalmol200449Suppl 1S45S5215016561
- WhitcupSMCantorLBVanDenburghAMChenKfor the Bimatoprost Study Group IIA randomised, double masked, multicentre clinical trial comparing bimatoprost and timolol for the treatment of glaucoma and ocular hypertensionBr J Ophthalmol2003871576212488264
- HigginbothamEJSchumanJSGoldbergIfor the Bimatoprost Study Groups 1 and 2One-year, randomized study comparing bimatoprost and timolol in glaucoma and ocular hypertensionArch Ophthalmol2002120101286129312365906
- WilliamsRDCohenJSGrossRLLiuC-CSafyanEBatoosinghALfor the Bimatoprost Study GroupLong-term efficacy and safety of bimatoprost for IOP lowering in glaucoma and ocular hypertension: Year 4Br J Ophthalmol200892101387139218621791
- WoodwardDFLiangYKraussAH-PProstamides (prostaglandin-ethanolamides) and their pharmacologyBr J Pharmacol2008153341041917721551
- Latisse [package insert]Irvine, CAAllergan, Inc2009
- SmithSFagienSSomogyiCWhitcupSMBeddingfieldFCEyelash growth in subjects treated with bimatoprost ophthalmic solution 0.03%; a multicenter, randomized, double-masked, vehicle-controlled, parallel studyPoster presented at the 67th annual meeting of the American Academy of DermatologyMarch 6–9, 2009San Francisco, CA
- LawSKBimatoprost in the treatment of eyelash hypotrichosisClin Ophthalmol2010434935820463804
- BrandtJDVanDenburghAMChenKWhitcupSMfor the Bimatoprost Study Group 1Comparison of once- or twice-daily bimatoprost with twice-daily timolol in patients with elevated IOP: A 3-month clinical trialOphthalmology200110861023103111382623
- BrandtJDCantorLBKatzLJBatoosinghALChouCBossowskaIBimatoprost/timolol fixed combination: A 3-month double-masked, randomized parallel comparison to its individual components in patients with glaucoma or ocular hypertensionJ Glaucoma200817321121618414107
- LewisRAGrossRLSallKNSchiffmanRMLiuCCBatoosinghALfor the Ganfort Investigators Group IIThe safety and efficacy of bimatoprost/timolol fixed combination: A 1-year double-masked, randomized parallel comparison to its individual components in patients with glaucoma or ocular hypertensionJ Glaucoma200919642442619855289
- KatzLJCohenJSBatoosinghALFelixCShuVSchiffmanRMTwelve-month, randomized, controlled trial of bimatoprost 0.01%, 0.0125%, and 0.03% in patients with glaucoma or ocular hypertensionAm J Ophthalmol20101494667119875089
- HollóGThe side effects of the prostaglandin analoguesExpert Opin Drug Saf200761455217181451
- ChenJDinhTWoodwardDFBimatoprost: Mechanism of ocular surface hyperemia associated with topical therapyCardiovasc Drug Rev200523323124616252016